Drugs Pricing in France - Balancing Innovation vs Cost Containment: The New Agreement between the Government and the Pharma industry
On January 11th 2016, the Comité Economique des Produits de Santé (CEPS - Economic Committee for Health Products) signed on the behalf of the French Government a new agreement, the Accord cadre, with Les entreprises du médicament (LEEM - pharmaceutical companies association) on how to set reimbursed drugs prices for the next 3 years. The CEPS is the body that negotiates drug prices with manufacturers.While details are lacking, the response of pharmaceutical companies is positive. Patrick Errard,...
To continue reading this story get free access
Please note: That all fields marked with an asterisk (*) are required.